Sangamo, Sigma-Aldrich, Roche deal

Roche received a non-exclusive, worldwide license to Sangamo’s zinc finger nuclease (ZFN) technology and an option to obtain an exclusive, worldwide license to commercialize therapeutics and diagnosti...